Wealth Advisors Of Tampa Bay, LLC Abb Vie Inc. Transaction History

Wealth Advisors Of Tampa Bay, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $4.02 Million - $4.76 Million	-44,791 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $267,289 - $357,925	-2,905 Reduced 6.09%	44,791 $4.24 Million
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $4.27 Million - $4.68 Million	47,696	47,696 $4.74 Million

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wealth Advisors Of Tampa Bay, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Advisors Of Tampa Bay, LLC with notifications on news.